Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden
· Delayed Price · Currency is SEK 56.70
-1.80 (-3.08%)
May 13, 2025, 4:59 PM CET
STO:IBT.B Revenue
Infant Bacterial Therapeutics AB had revenue of -1.00K SEK in the twelve months ending March 31, 2025, down -101.45% year-over-year. In the year 2024, Infant Bacterial Therapeutics AB had annual revenue of 4.00K, down -94.81%.
Revenue (ttm)
-1.00K
Revenue Growth
-101.45%
P/S Ratio
-788,078.07
Revenue / Employee
-125.00
Employees
8
Market Cap
788.08M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |